Castellina Ventures Ltd. 13D and 13G filings for Idera Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-07 4:36 pm Purchase |
2022-05-18 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 329,529 5.300% |
70,706 (+27.32%) |
Filing |
| 2022-02-08 1:31 pm Purchase |
2021-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 258,824 4.200% |
2,768 (+1.08%) |
Filing |
| 2021-02-12 3:45 pm Sale |
2020-12-31 | 13G | Idera Pharmaceuticals, Inc. IDRA |
Castellina Ventures Ltd. | 256,055 6.200% |
-8,455 (-3.20%) |
Filing |